Human subjects were exposed by inhalation to 250, 500, and 1000 ppm 1,
1-dichloro-1-fluoroethane (HCFC-141b) for 4 hr, and urine samples were
collected from 0-4, 4-12, and 12-24 hr for metabolite analysis. F-19
nuclear magnetic resonance spectroscopic analysis of urine samples fro
m exposed subjects showed that 2,2-dichloro-2-fluoroethyl glucuronide
and dichlorofluoroacetic acid were the major and minor metabolites, re
spectively, of HCFC-141b, Urinary 2,2-dichloro-2-fluoroethyl glucuroni
de was hydrolyzed to 2,2-dichloro-2-fluoroethanol by incubation with b
eta-glucuronidase, and the released 2,2-dichloro-2-fluoroethanol was q
uantified by gas chromatography/mass spectrometry. Concentrations of 2
,2-dichloro-2-fluoroethanol were highest in the urine samples collecte
d 4-12 hr after exposure, but 2,2-dichloro-2-fluoroethanol was also de
tected in the samples collected 0-4 and 12-24 hr after exposure. Expos
ure concentration-dependent excretion of 2,2-dichloro-2-fluoroethanol,
obtained by hydrolysis of 2,2-dichloro-2-fluoroethyl glucuronide, was
observed in seven of the eight subjects studied. In conclusion, HCFC-
141b is metabolized in human subjects to 2,2-dichloro-2-fluoroethanol,
which is conjugated with glucuronic acid and excreted as its glucuron
ide in urine in a time- and exposure concentration-dependent manner.